Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Aristo Bio-Tech & Lifescience Ltd

ARISTO
NSE
116.00
2.16%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Aristo Bio-Tech & Lifescience Ltd

ARISTO
NSE
116.00
2.16%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
79Cr
Close
Close Price
116.00
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
21.48
PS
Price To Sales
0.22
Revenue
Revenue
360Cr
Rev Gr TTM
Revenue Growth TTM
10.39%
PAT Gr TTM
PAT Growth TTM
-37.31%
Peer Comparison
How does ARISTO stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
ARISTO
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025
Revenue
RevenueCr
937312989133112214104256
Growth YoY
Revenue Growth YoY%
39.321.52.926.561.2-7.519.8
Expenses
ExpensesCr
887212485128109206103249
Operating Profit
Operating ProfitCr
415453818
OPM
OPM%
4.71.23.94.14.02.93.81.13.1
Other Income
Other IncomeCr
000000000
Interest Expense
Interest ExpenseCr
111211111
Depreciation
DepreciationCr
111111111
PBT
PBTCr
304243717
Tax
TaxCr
101011101
PAT
PATCr
203131504
Growth YoY
PAT Growth YoY%
46.3403.0-0.832.077.0-137.1-8.3
NPM
NPM%
1.9-0.52.01.11.91.22.1-0.51.6
EPS
EPS
0.00.00.01.53.81.96.7-0.76.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
57160271202201167166218245318360
Growth
Revenue Growth%
180.369.6-25.7-0.2-16.9-0.931.412.529.813.3
Expenses
ExpensesCr
56158264195197163161209237309351
Operating Profit
Operating ProfitCr
13775459899
OPM
OPM%
1.61.62.73.42.22.63.14.03.52.92.5
Other Income
Other IncomeCr
01100000000
Interest Expense
Interest ExpenseCr
01223223222
Depreciation
DepreciationCr
00011112233
PBT
PBTCr
13641225558
Tax
TaxCr
01210011211
PAT
PATCr
02431114444
Growth
PAT Growth%
365.3101.9-24.3-64.46.833.3148.49.44.3-9.4
NPM
NPM%
0.71.21.41.40.50.60.91.61.61.31.0
EPS
EPS
4.018.537.45.72.02.12.95.25.76.05.4

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
1115555777
Reserves
ReservesCr
24767810232731
Current Liabilities
Current LiabilitiesCr
24787072655651598496
Non Current Liabilities
Non Current LiabilitiesCr
0511711121110108
Total Liabilities
Total LiabilitiesCr
27878991888177100127141
Current Assets
Current AssetsCr
2584818177696383105116
Non Current Assets
Non Current AssetsCr
23810111214172225
Total Assets
Total AssetsCr
27878991888177100127141

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1-418127-3810
Investing Cash Flow
Investing Cash FlowCr
00-5-2-2-2-3-4-7-5
Financing Cash Flow
Financing Cash FlowCr
044-61-1-38-2-4
Net Cash Flow
Net Cash FlowCr
00000001-10
Free Cash Flow
Free Cash FlowCr
0-408114-515
CFO To PAT
CFO To PAT%
155.4-214.622.8288.1139.7212.3472.7-78.1195.1246.5
CFO To EBITDA
CFO To EBITDA%
65.9-157.511.6119.531.252.6131.0-32.089.5108.0

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0000000384379
Price To Earnings
Price To Earnings
0.00.00.00.00.00.00.010.710.919.5
Price To Sales
Price To Sales
0.00.00.00.00.00.00.00.20.20.3
Price To Book
Price To Book
0.00.00.00.00.00.00.01.31.32.1
EV To EBITDA
EV To EBITDA
4.53.92.72.04.35.14.86.87.410.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
11.57.97.78.76.810.311.310.17.77.1
OPM
OPM%
1.61.62.73.42.22.63.14.03.52.9
NPM
NPM%
0.71.21.41.40.50.60.91.61.61.3
ROCE
ROCE%
14.223.626.124.712.510.110.814.213.012.0
ROE
ROE%
13.839.144.125.08.28.09.711.811.610.9
ROA
ROA%
1.52.14.23.11.11.31.93.63.12.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Aristo Bio-Tech and Life Science Limited (NSE: **ARISTO**) is a prominent Indian agrochemical player specializing in the manufacturing, formulation, supply, and packaging of crop protection solutions. The company serves as a critical link in the agricultural value chain, providing a diverse range of products designed to mitigate crop loss—which currently claims **30-35%** of India’s annual yield—and enhance global food security. --- ### **Integrated Business Model & Service Architecture** Aristo operates a dual-revenue model that combines proprietary product sales with high-value contract manufacturing and professional consultancy. * **Agrochemical Manufacturing & Formulation:** The company produces a comprehensive portfolio including **Insecticides, Herbicides, Fungicides, and Plant Growth Regulators**. * **Contract Job Work:** Aristo provides specialized **packaging and job work services**, tailoring formulations and delivery systems to the specific requirements of domestic and international institutional clients. * **Professional Financial Services:** Uniquely, the firm maintains a specialized division providing **Audit, Taxation, and Management Consultancy**. This branch handles complex corporate actions including **U.S./U.K. GAAP conversions**, **Project Finance (loan syndication)**, and **Statutory Audits** for nationalized banks and private entities. --- ### **Manufacturing Infrastructure & Quality Assurance** The company’s operational backbone is centered in Gujarat, leveraging state-of-the-art technology to maintain rigorous global standards. * **Production Hub:** Located at **G.I.D.C. Manjusar, Vadodara**, the facility spans three strategic plots (**E-24, 25, and 26**). * **Advanced Laboratory Capabilities:** In-house quality control is managed via **High Performance Liquid Chromatography (HPLC)**, **Ultraviolet Spectrography (UV)**, and **Gas Chromatography (GC)** to ensure the integrity of raw materials and finished goods. * **Regulatory Compliance:** All packaging (HDPE, Tin, Pet bottles) adheres strictly to **FAO** and **Bureau of Indian Standards (BIS)** guidelines. * **Sustainable Operations:** The company has integrated **solar technologies** for facility lighting and is actively researching **eco-friendly, low-toxicity formulations** and **biological agrochemicals**. --- ### **Market Reach & Strategic Partnerships** Aristo has established a robust footprint across both domestic and international agricultural markets. * **Domestic Presence:** Supplies products across **20 Indian states**, with deep penetration in major hubs like **Punjab, Maharashtra, Gujarat, and Uttar Pradesh**. * **Global Export Footprint:** Currently exports to **15 countries**, including **Germany, Italy, Australia, South Africa, UAE, and Vietnam**. * **Institutional Empanelment:** A significant growth driver is the company’s empanelment with **National Fertilizers Limited (NFL)**. As an approved supplier of **Technical Grade Molecules**, Aristo supports NFL’s **Bathinda Unit**, securing a steady stream of high-volume institutional orders. --- ### **Financial Performance & Capital Structure** Aristo has demonstrated consistent top-line and bottom-line growth, meeting key revenue and debt reduction guidance. | Metric | FY 2023-24 | FY 2022-23 | Growth (%) | | :--- | :--- | :--- | :--- | | **Revenue from Operations** | **₹ 245.15 Crore** | **₹ 217.86 Crore** | **12.53%** | | **Net Profit** | **₹ 3.90 Crore** | **₹ 3.56 Crore** | **9.36%** | | **Export Sales** | **₹ 7.93 Crore** | - | - | | **Import Purchases** | **₹ 6.30 Crore** | - | - | **Capital & Shareholder Information:** * **Authorized Share Capital:** **Rs. 8,00,00,000** * **Paid-up Share Capital:** **Rs. 6,80,78,000** (comprising **68,07,800** equity shares). * **Dividend Policy:** Declared a final dividend of **₹ 0.4 per share** (**4%**) for FY 2023-24. * **Investment Capacity:** Shareholders approved an increase in investment and loan limits up to **Rs. 150.00 Crores** under **Section 186**, providing significant "dry powder" for strategic acquisitions or corporate lending. --- ### **Order Book Momentum (FY 2025-26)** The company has secured a high-velocity order book from both global corporations and Indian PSUs: | Client | Product/Category | Value (Approx.) | | :--- | :--- | :--- | | **National Fertilizers Ltd (NFL)** | Various Agrochemicals (Multiple LOIs) | **₹ 24.41 Crore (Cumulative)** | | **Hindustan Agro** | Cypermethrin, Fipronil, Alphalite | **₹ 2.42 Crore** | | **Sinochem India** | **Glyphosate Technical 95%** | **₹ 3.45 Crore** | | **DVA Agro GmbH (Germany)** | **THODAN SUPER 35 SC** | **USD 230,805 (~₹1.98 Cr)** | | **AVIMA (Pty) Ltd** | Chemicals (Overseas) | **USD 144,000 (~₹1.32 Cr)** | | **Mizushi India Pvt Ltd** | Various Agrochemicals | **₹ 1.52 Crore** | --- ### **Strategic Growth Drivers & Product Innovation** Aristo is positioning itself to capitalize on the projected **8-10% growth rate** of the Indian agrochemical sector through 2025. * **Technical Grade Expansion:** Secured **Section 9(4) Registrations** for the import of **Acetamiprid Technical 99%** and **Atrazine Technical 98%**, allowing for higher-margin production. * **Product Pipeline:** Holds **257 products** registered with the **CIB&RC**, providing a massive library of solutions for diverse pest profiles. * **Digital Agriculture:** Participation in the **"Digital Agriculture Mission"** to modernize supply chains and leverage AI-driven platforms for precision farming. * **Macro Tailwinds:** Rising global population (projected **970 crore by 2050**) and declining arable land per capita necessitate the intensive crop protection Aristo provides. --- ### **Risk Factors & Governance Framework** Investors should monitor several operational and regulatory challenges inherent to the sector. * **Climatic & Inventory Risk:** Erratic rainfall can lead to **weak demand** and **elevated inventory levels**, which recently caused **increased sales returns** and margin compression. * **Global Competition:** Stiff competition from **low-cost Chinese imports** remains a persistent threat to domestic pricing power. * **Regulatory Compliance:** The company operates under the **Insecticides Act (1968)** and **SEBI Regulations**. It has previously faced an **NSE SOP fine** (May 2024) for delays in appointing a Qualified Company Secretary and procedural lapses in maintaining the **Structured Digital Database (SDD)**. * **Management Evolution:** The Board has revised the remuneration for **CMD Narendra Singh Barhat** to a ceiling of **₹ 75,00,000 per annum** (effective Sept 2025), reflecting the company's scaling operations and increased management responsibilities.